Our data supported that LILRB4 signal pathway promoted the differentiation and mature of osteoclasts by secreting RELT, and LILRB4 had the potential to be a new target for the treatment of multiple myeloma. The gene discussed is LILRB4; the disease is AL amyloidosis.